In a separate AML patient (Patient 3, Table 1), FISH analysis using a break-apart probe specific for the CBFB gene (16q22) revealed a signal pattern indicative of a deletion in 70% of the interphase nuclei, which was also confirmed by karyotyping. This evidence concerns the gene CBFB and acute myeloid leukemia.